Aurobindo Pharma to acquire Sandoz US dermatology and oral solids divisions for $1bn

Aurobindo Pharma, a prominent Indian pharmaceutical company, has agreed to a significant acquisition from Sandoz US, a division of the Swiss pharmaceutical giant Novartis. The ... Read More